Tg Therapeutics TGTX
NASDAQ TGTX
$53.20 -1.33 (-2.44%)
At close: Oct 21, 2026 · 4:00 PM EDT

Tg Therapeutics (TGTX) Acquisitions (2011)

Updated

Tg Therapeutics' Acquisitions came in at $10,386 for FY2012.

Analysis

Tg Therapeutics (TGTX) Acquisitions (2011) Analysis & Trends

  • Per Business Quant, earlier years put Acquisitions at $10,386 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -17.24 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.21 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Tg Therapeutics 7.56 Bn 6.94 Bn 199.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 -10,386.00
API Access

Tg Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=TGTX&period=max&api_key=YOUR_API_KEY